4//SEC Filing
SAGAN PAUL 4
Accession 0001127602-22-012858
CIK 0001682852other
Filed
May 1, 8:00 PM ET
Accepted
May 2, 4:42 PM ET
Size
11.8 KB
Accession
0001127602-22-012858
Insider Transaction Report
Form 4
Moderna, Inc.MRNA
SAGAN PAUL
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-04-28+5,415→ 5,415 totalExercise: $142.52→ Common Stock (5,415 underlying) - Exercise/Conversion
Common Stock
2022-04-28+703→ 703 total - Exercise/Conversion
Restricted Stock Units
2022-04-28−703→ 0 totalExercise: $0.00→ Common Stock (703 underlying)
Holdings
- 76,452(indirect: By Trust)
Common Stock
- 370,407(indirect: By Trust)
Common Stock
- 14,951(indirect: By LLC)
Common Stock
Footnotes (4)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]Erwin Park LLC is an investment vehicle owned by the Reporting Person's children. The Chatham Trust is an irrevocable family trust for which the Reporting Person serves as a trustee. The Paul Sagan Revocable Trust is a revocable trust for which the Reporting Person serves as a trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- [F3]The shares subject to this restricted stock unit award vested in full on April 28, 2022.
- [F4]This option will become fully vested and exercisable on the earlier of April 28, 2023, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service.
Documents
Issuer
Moderna, Inc.
CIK 0001682852
Entity typeother
Related Parties
1- filerCIK 0001035440
Filing Metadata
- Form type
- 4
- Filed
- May 1, 8:00 PM ET
- Accepted
- May 2, 4:42 PM ET
- Size
- 11.8 KB